image

The best stocks to buy since 1993

Latest issue now available

Eros

December 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • EROS
  • Price:
  • 255p
Eros has reported excellent interims with sales up by a third to US$92m and EBITDA up 37% to US$70.3m. Profit before tax, which is after content amortisation, was up 4% to US$29m. Adjusting for the various funnies on the Indian minority interest, eps equates to being up 6% to 18.6 cents.   Eros' new found strategy of targeting bigger budget films supported by the rising number of multiplex cinemas in India saw its theatrical sales go gangbusters  (+94% to US$44.8m). The box office success also boosted TV syndication sales (+11% to US$24.5m). Counter intuitively the involvement in bigger films lowers risk as they feature bigger stars but this does push up content amortisation costs. Overall, there were 42 film ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe